From: Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study
Toxic effects
conversion therapy (n = 18)
palliative chemotherapy (n = 20)
Hematological
Leucopenia/neutropenia
3(16.7%)
3(15.0%)
Thrombocytopenia
1(5.6%)
1(5.0%)
Non-hematological
Transaminase elevation
2(11.1%)